# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000849146-23-000184
Filing Date
2023-10-16
Accepted
2023-10-13 18:16:32
Documents
2

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14a-investorpresentati.htm | DEFA14A | 12014
2 | EXHIBIT 1 - INVESTOR PRESENTATION | lfvnoctober2023investorpre.pdf | DEFA14A | 5741561
| Complete submission text file | 0000849146-23-000184.txt |  | 7906069

Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-35647 | Film No.: 231325897
SIC: 2834 Pharmaceutical Preparations